Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors

Coronaviruses, including SARS‐CoV‐2, possess an mRNA 5′ capping apparatus capable of mimicking the natural eukaryotic capping signature. Two SAM‐dependent methylating enzymes play important roles in this process: nsp14 methylates the N7 of the guanosine cap, and nsp16‐nsp10 methylates the 2′‐O‐ of s...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem Vol. 19; no. 24; pp. e202400618 - n/a
Main Authors: Kalnins, Gints, Rudusa, Laura, Bula, Anna L., Zelencova‐Gopejenko, Diana, Bobileva, Olga, Sisovs, Mihails, Tars, Kaspars, Jirgensons, Aigars, Jaudzems, Kristaps, Bobrovs, Raitis
Format: Journal Article
Language:English
Published: Germany Wiley Subscription Services, Inc 16.12.2024
John Wiley and Sons Inc
Subjects:
ISSN:1860-7179, 1860-7187, 1860-7187
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coronaviruses, including SARS‐CoV‐2, possess an mRNA 5′ capping apparatus capable of mimicking the natural eukaryotic capping signature. Two SAM‐dependent methylating enzymes play important roles in this process: nsp14 methylates the N7 of the guanosine cap, and nsp16‐nsp10 methylates the 2′‐O‐ of subsequent nucleotides of viral mRNA. The 2′‐O‐methylation performed by nsp16‐nsp10 is crucial for the escape of the viral RNA from innate immunity. Inhibition of this enzymatic activity has been proposed as a way to combat coronaviruses. In this study, we employed X‐ray crystallography to analyze the binding of the SAM analogues to the active site of nsp16‐nsp10. We obtained eleven 3D crystal structures of the nsp16‐nsp10 complexes with SAM‐derived inhibitors, demonstrated different conformations of the methionine substituting part of the molecules, and confirmed that simultaneous dual‐site targeting of both SAM and RNA sites correlates with higher inhibitory potential. Structural information on the binding of S‐adenosyl methionine (SAM) analogues to SARS‐CoV‐2 nsp16 shows that targeting both the SAM and RNA binding sites simultaneously enhances inhibitory potential.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1860-7179
1860-7187
1860-7187
DOI:10.1002/cmdc.202400618